| Dr Rueywen Chen, MD | |
|
16605 Southwest Fwy Ste 400, Sugar Land, TX 77479-3500 | |
| (281) 275-0800 | |
| Not Available |
| Full Name | Dr Rueywen Chen |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 22 Years |
| Location | 16605 Southwest Fwy Ste 400, Sugar Land, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548257884 | NPI | - | NPPES |
| 190474002 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | M1582 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Advanced Healthcare Services Inc | Houston, TX | Home health agency |
| Houston Methodist Sugarland Hospital | Sugar land, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tmh Physician Associates Pllc | 4486711744 | 1557 |
News Archive
Limited-time program to help companies and investigators de-risk thawing of cell therapies in early stage clinical trials.
In other news related to the legal challenges, the parties involved in the lawsuits differ not only on questions related to the overhaul, but also on the allocation of time for arguments.
"Because they strike mostly forgotten people living on less than $2 per day, [neglected tropical diseases (NTDs)] have traditionally been thought of as a problem exclusive to low-income countries, especially in sub-Saharan Africa," Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine and president and director of the Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, writes in a Foreign Policy opinion piece
Gene therapy to replace the protein missing in Pompe disease can be effective if the patient's immune system does not react against the therapy. Targeted delivery of the gene to the liver, instead of throughout the body,suppresses the immune response, improving the therapeutic effect, according to an article published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc.
Initially, the drug was developed to treat rheumatoid arthritis. BIOCAD developers receive regulatory authorization as part of the procedure approved by Decree No. 441 of the Government of the Russian Federation of April 4, 2020 since the mechanism of action of the active substance is associated with the cytokine storm, a life-threatening immune system response in patients with COVID-19.
› Verified 6 days ago
| Entity Name | Tmh Physician Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275779225 PECOS PAC ID: 4486711744 Enrollment ID: O20090401000100 |
News Archive
Limited-time program to help companies and investigators de-risk thawing of cell therapies in early stage clinical trials.
In other news related to the legal challenges, the parties involved in the lawsuits differ not only on questions related to the overhaul, but also on the allocation of time for arguments.
"Because they strike mostly forgotten people living on less than $2 per day, [neglected tropical diseases (NTDs)] have traditionally been thought of as a problem exclusive to low-income countries, especially in sub-Saharan Africa," Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine and president and director of the Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, writes in a Foreign Policy opinion piece
Gene therapy to replace the protein missing in Pompe disease can be effective if the patient's immune system does not react against the therapy. Targeted delivery of the gene to the liver, instead of throughout the body,suppresses the immune response, improving the therapeutic effect, according to an article published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc.
Initially, the drug was developed to treat rheumatoid arthritis. BIOCAD developers receive regulatory authorization as part of the procedure approved by Decree No. 441 of the Government of the Russian Federation of April 4, 2020 since the mechanism of action of the active substance is associated with the cytokine storm, a life-threatening immune system response in patients with COVID-19.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rueywen Chen, MD 16605 Southwest Fwy Ste 400, Sugar Land, TX 77479-3500 Ph: (281) 275-0800 | Dr Rueywen Chen, MD 16605 Southwest Fwy Ste 400, Sugar Land, TX 77479-3500 Ph: (281) 275-0800 |
News Archive
Limited-time program to help companies and investigators de-risk thawing of cell therapies in early stage clinical trials.
In other news related to the legal challenges, the parties involved in the lawsuits differ not only on questions related to the overhaul, but also on the allocation of time for arguments.
"Because they strike mostly forgotten people living on less than $2 per day, [neglected tropical diseases (NTDs)] have traditionally been thought of as a problem exclusive to low-income countries, especially in sub-Saharan Africa," Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine and president and director of the Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, writes in a Foreign Policy opinion piece
Gene therapy to replace the protein missing in Pompe disease can be effective if the patient's immune system does not react against the therapy. Targeted delivery of the gene to the liver, instead of throughout the body,suppresses the immune response, improving the therapeutic effect, according to an article published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc.
Initially, the drug was developed to treat rheumatoid arthritis. BIOCAD developers receive regulatory authorization as part of the procedure approved by Decree No. 441 of the Government of the Russian Federation of April 4, 2020 since the mechanism of action of the active substance is associated with the cytokine storm, a life-threatening immune system response in patients with COVID-19.
› Verified 6 days ago
Monica Kalra, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14023 Southwest Fwy, Sugar Land, TX 77478 Phone: 281-325-4100 | |
Dr. Brent Devin Reed, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 15200 Southwest Fwy Ste 175, Sugar Land, TX 77478 Phone: 713-461-2915 Fax: 713-461-5307 | |
Robbyn Lucille Traylor, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2415 Town Center Dr, Ste 300, Sugar Land, TX 77478 Phone: 281-201-0657 | |
Dr. Cedela Abdulla, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3533 Town Center Blvd S, Ste. 200, Sugar Land, TX 77479 Phone: 713-772-0793 Fax: 281-781-2557 | |
Wyntria Lacabe-moore, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1403 Highway 6, Sugar Land, TX 77478 Phone: 832-260-0640 | |
Dr. Abraham K. Peringol, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 14815 Southwest Fwy, Sugar Land, TX 77478 Phone: 281-565-2140 Fax: 281-565-2174 | |
Owen Capocyan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4911 Sandhill Dr, Sugar Land, TX 77479 Phone: 816-334-9302 |